DEPARTMENT OF PERIODONTOLOGY AND ORAL PATHOLOGY

DEPARTMENT OF PERIODONTOLOGY AND ORAL PATHOLOGY

The mission of the department of Periodontology and Oral pathology is to promote in excellence in teaching, learning, research and creative activities, patient- centered care and professional service that will advance the oral health as well as the overall health of the people.

The department of periodontology and oral pathology has three sub wings.

Periodontology is concerned with establishing and maintaining health for the structures that supports teeth. Periodontology is engaged in the treatment of problems associated with gums and poor oral hygiene. These includes scaling and root planning, splinting, abscess drainage. Surgeries such as flap surgery are conducted here.

Oral pathology is the study of the diseases of the soft and calcified structures of the oral cavity. It focuses on the nature, identification and management of diseases affecting the oral tissues. Oral pathology bridges two aspects of the health sciences: basic science and clinical practice. Knowledge is applied to clinical situation and various histological, molecular, and others parameters are used to determine diagnoses.

Oral medicine interfaces dentistry and medicine and is concerned with the health care patients with acute, chronic, recurrent and medically-related disorders of the oral and maxillofacial region including chronic facial pain. Oral medicine is involved in patient care, teaching and research involving diagnosis and nonsurgical management of diseases of orofacial complex and behavioral disorders that impact oral health.

ONLY INDIVIDUAL ORAL PATHOLOGY LAB IN BANGLADESH

The laboratory provides oral diagnostic histopathology service with histopathologic analysis of biopsy specimen submitted.

Departments

Faculty Members

PROFESSOR ASAD-UZ-ZAMAN

BDS, DDS, PhD(Japan)

Professor
Department of Oral Pathology and Periodontology
Sapporo Dental College & Hospital 

Umma Habiba
BDS, DDS, MCPS, PhD

Associate Professor and Head
Department of Oral Pathology and Periodontology
Sapporo Dental College & Hospital 

Visiting Researcher
Department of Cancer Pathology
Hokkaido University Faculty of Medicine. Japan

Dr MUHAMMAD MARUF HOSSAIN

BDS from Dhaka Dental College and hospital 2000
MPH from North South University 2008
BMDC registration 1227

DR ZINIA MAHMUD

Masters of Public Health (MPH) from American International University Bangladesh (AIUB) 2016

Bachelor of Dental Surgery (BDS) from Dhaka University from 2005

 

DR RAFIZ AHMED

Young and energetic fellow of the department. He stadied in govt laboratory high school and CODA.He completed his BDS from Sapporo dental college in 2009.

He  done a hands on course in dental implantology by OSSTEM

He join in Sapporo dental college in 2011 as a lecturer.

His passion is football & loves to watch every single match particularly with his friends and fellows.

Dr. ROWNAK RAHAD

Dr Rownak Rahad completed his BDS in 2014 from a renowned dental college in Bangladesh,Sapporo  Dental College. He studied in Adarsha school Narayanganj & Narayanganj College.He did his post-graduation training from Dhaka Dental College.

He joined his own college as a lecturer in 2018 to serve more.

He loves to take care of plants and pets in his leisure time.

DR.TARANNUM SHAHID

The youngest fellow of the department who passed her BDS in 2013  from a institution of excellence , Sapporo Dental College. She studied in Nawab Faizunnessa Govt. Girl’s High School & Cumilla Victoria college. She did her post graduation training from Dhaka Dental College.

She joined in this institution as a lecturer in 2021.

She enjoys out with her husband and her loving son.

PUBLICATIONS                                                                                                                                                                                     

  1. ORIGINAL ARTICLES
  2. Habiba U, Sugino H, Yordanova R, Ise K, Tanei Z, Ishida Y, Tanikawa S, Terasaka S, Sato K, Kamoshima Y, Katoh M, Nagane M, Shibahara J, Tsuda M, Tanaka S: Loss of H3K27 trimethylation is frequent in IDH1‑R132H but not in non‑canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study. Acta Neuropathol Commun, 9:95, 2021, Citation: 12, IF: 6.2.
  3. Mikawa Y, Alam MT, Hossain E, Matsuda AY, Kitamura T, Yasuda M, Habiba U, Ahmed I, Kitagawa Y, Shindoh M, Higashino F: Conditionally Replicative Adenovirus Controlled by the Stabilization System of AU-Rich Elements Containing mRNA. Cancers 12(5):1205, 2020, Citation: 2, IF: 2
  4. Hossain E, Habiba U, Matsuda AY, Alam A, Ahmed I, Alam MT, Yasuda M, Higashino F: Advantages of Using Paclitaxel in Combination with Oncolytic Adenovirus Utilizing RNA Destabilization Mechanism. Cancers 12(5):1210, 2020, Citation: 6, IF: 5.2
  5. Habiba U *, Hossain E, Matsuda AY, Chowdhury AFMA, Tsuda M, Zaman A uz, Tanaka S, Higashino F: Cisplatin Relocalizes RNA Binding Protein HuR and enhances the Oncolytic Activity of E4orf6 deleted Adenovirus. Cancers 12(4):809, 2020, Citation: 11, IF: 5.2.
  6. Matsuda AY, Mikawa Y, Habiba U, Kitamura T, Yasuda M, Kitagawa Y, Shindoh M, Higashino F: Oncolytic potential of an E4-deficient adenovirus that can recognize ARE-mRNA stabilization in cancer cells. Oncol Rep 41(2):954-960. 2019, Citation: 12, IF: 3.8.
  7. Habiba U, Kuroshima T, Matsuda AY, Kitamura T, Chowdhury AFMA, Jehung J.P, Hossain E, Sano H, Kitagawa Y, Shindoh M, Higashino F: HuR translocation to the cytoplasm of cancer cells in actin-independent manner. Cell Res 369, 218 – 225, 2018 Citation: 8, IF: 3.3.
  8. Habiba U, Hida K, Kitamura T, Matsuda AY, Higashino F, ITO M Yochi, Ohiro Y, Totsuka Y, Shindoh M: ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia. Oncol Lett 13, 321-328, 2017, Citation: 41, IF: 2.
  9. Hida K, Maishi N, Muhyia Annan D, Kondoh M, Hojo T, Habiba U, Ohga N, Ishikawa K, Sato M, Torii C, Yanagiya M, Morimoto M, Hida Y, Shindoh M: Aneuploidy of a murine immortalized endothelial cell line, MS1. Oral Biosci 59, 50-54, 2017, Citation: 1, IF: 2.6.
  10. Habiba U, Kitamura T, Matsuda AY, Higashino F, Hida K, Totsuka Y, Shindoh M: HuR and podoplanin expression is associated with a high risk of malignant transformation in patients with oral preneoplastic lesions. Oncol Lett 12, 3199-3207, 2016, Citation: 12, IF: 2.5.
  11. Habiba U, Kitamura T, Matsuda AY, Hida K, Higashino F, Ohiro Y, Totsuka Y, Shindoh M: Cytoplasmic expression of HuR may be a valuable diagnostic tool for determining the potential for malignant transformation of oral verrucous borderline lesions. Oncol Rep 31,1547-54, 2014, Citation: 19, IF: 3.8.
  12. Hannan MA, Chowdhury MTH, Khan MAI, Chowdhury AFMA. Habiba U, Shahidullah KM, Anjum A: Caries prevalence among Bangladeshi slum population: A cross-sectional study. Journal of Contemporary Dental Sciences 1, 11-14, 2013, Citation: 0, IF: 0.
  13. Hussain SMI, Chowdhury AFMA, Habiba U, Alam MS, Aich SK, Mahmud AA: Atraumatic Restorative Treatment (ART) approach: Evolution, feasibility, and implementation in Bangladesh. Journal of Oral Health 14, 1-3, 2012, Citation: 0, IF: 0.
  14. Chowdhury AFMA. Alam MS, Habiba U, Aich SK, Sultana A, Muktadir G: Recent trends in the diagnosis and management of dentin hypersensitivity. Journal of Oral Health 14, 36-39, 2012, Citation: 0, IF: 0.
  15. Aich SK, Hossain E, Alam A, Chowdhury AFMA, Habiba U, Mahmud AA: Professional behavior and attitude: Ethics of a Dental Surgeon. Journal of Oral Health 14, 48-50, 2012, Citation: 0, IF: 0.
  16. CASE REPORT
  17. Chowdhury AFMA, Alam A, Sarkar UK, Mahmud AA, Habiba U, Rabby MAI: Apexification with Calcium Hydroxide: 27 Months Follow Up of a Case: MEDICINE today 25, 42-45, 2013, Citation: 2, IF: 0.

 

PRESENTATIONS AT SCIENTIFIC CONFERENCES       

  1. “Loss of H3K27me3 is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated oligodendroglioma: a Japanese cohort study “, Habiba U, Sugino H, Tanei Z, Ishida Y, Tanikawa S, Tsuda M, Tanaka S, “54th Hokkaido Medical Congress “, Sapporo (Japan), (2021.9).
  2. “H3K27me3 expression correlates the diagnosis of IDH mutant, and 1p/19q co deleted oligodendroglioma “, Habiba U, Sugino H, Tanei Z, Ishida Y, Tanikawa S, Tsuda M, Tanaka S, ” The 38th Annual Meeting of the Japan Society of Brain Tumor Pathology “, Hokkaido (Japan), (2020.10).
  3. “Synergistic cytotoxicity of oncolytic Adenovirus in combination with cisplatin chemotherapy, “Habiba U, Matsuda AY, Kitamura T, Hossain E, Tsuda M, Hida K, Tanaka S, Higashino F, “38th Sapporo International Cancer Symposium “, Hokkaido (Japan), (2019.7).
  1. “Enhancement of tumor cell death by combining cisplatin with E4orf6 gene deleted oncolytic adenovirus”, Habiba U, Kitamura T, Matsuda AY, Elora Hossain, Higashino F, “The 60th annual meeting of Japanese Association for Oral Biology”, Fukuoka (Japan), (2018.9).
  2. “Evaluation of cytoskeleton dependent relocalization of HuR in cancer cells,” Habiba U, Kitamura T, Matsuda AY, Hossain E and Higashino F, The 3rd annual symposium for young researchers in cutting-edge life science, Sapporo (Japan), (2018.1).
  3. “Evaluation of cytoskeleton dependent relocalization of HuR in cancer cells,” Habiba U, Kitamura T, Matsuda AY, Higashino F and Masanobu Shindoh, The 28th Annual Meeting of the Japanese Society of Oral Pathology. Kawagoe (Japan), (2017.8).
  4. “Cancer therapy by combining oncolytic adenovirus with anticancer drug,” Habiba U, Kitamura T, Matsuda AY, Higashino F and Shindoh M, The 27th Annual Meeting of the Japanese Society of Oral Pathology, Hiroshima (Japan), (2016.8).
  5. “ALDH1 and podoplanin expression in oral leukoplakia: Correlate with malignant transformation risk”, Habiba U, Hida K, Kitamura T, Matsuda AY, Higashino F and Shindoh M, The106th Annual Meeting of the American Association for Cancer Research (AACR)”, Pennsylvania (USA), (2015.4).
  6. “CD44s and CD44v6 expression in oral leukoplakia and their prognostic significance”, Habiba U, Kitamura T, Matsuda AY, Higashino F, Hida K and Shindoh M, The104th Annual meeting of the Japanese society of pathology. Nagoya, (Japan), (2015.4).
  7. “Expression patterns of cáncer stem cell markers ALDH1 and Podoplanin in oral leukoplakia and the risk of malignant transformation”, Habiba U, Hida K, Kitamura T, Matsuda AY, Higashino F, Ito M Y, Ohiro Y, Totsuka Y and Shindoh M. The 25th Annual Meeting of the Japanese Society of Oral Pathology”, Niigata (Japan), (2014.8).
  8. “Overexpression of HuR and Podoplanin may predict the development of oral cancer,” Habiba U, Kitamura T, Matsuda AY, Higashino F, Yasunori T and Shindoh M, The 17th International Congress on Oral Pathology and Medicine”, Istanbul (Turkey), (2014.5).
  9. “Overexpression of podoplanin and HuR may predict the development of oral cancer in patients with oral epithelial dysplasia,” Habiba U, Kitamura T, Matsuda AY, Higashino F and Shindoh M, The 24th Annual Meeting of the Japanese Society of Oral Pathology, Tokyo (Japan), (2013.8).
  1. “Cytoplasmic expression of HuR could be a useful diagnostic tool to determine malignant transformation of oral verrucous borderline

        lesions,” Habiba U, Kitamura T, Matsuda AY, Higashino F and Shindoh M, The 23rd Annual Meeting of the Japanese Society of Oral

        Pathology, Tokyo (Japan), (2012.8).

RESEARCH/ CLINICAL/PATHOLOGICAL COLLABORATION

  1. Department of Cancer Pathology, Hokkaido University Graduate School of Medicine
  2. Department of Periodontology, Hokkaido University Graduate School of Dental Medicine
  3. Department of Pathology, Bangabandhu Sheikh Mujib Medical University (BSMMU)
  4. Department of Oral and Maxillofacial Pathology, Bangabandhu Sheikh Mujib Medical University (BSMMU)
  5. Department of Oral and Maxillofacial Surgery, Bangabandhu Sheikh Mujib Medical University (BSMMU)

RESEARCH GRANTS

  1. Grant name and Number: Research Grant for Early Career Scientist; Number: 22K17010 (Grants in Aid for Scientific Research; Japan Society for the Promotion of Science)

Research Project Title: Development of a method for rapid induction of head and neck cancer stem cells for innovation of personalized therapeutic modality

Duration: April 2022 – March 2025

Grant Amount: 3,500,000 Japanese Yen

Role: Principal Investigator

  1. Grant name and Type: JSPS Fellowship Research fund; Standard (Grants in Aid for Scientific Research; Japan Society for the Promotion of Science)

Research Project Title: Application study of newly developed oncolytic Adenovirus

Duration: April 2017 – March 2019

Grant Amount: 2,300,000 Japanese Yen

Role: Co-Investigator

  1. Grant name and number: Wakate B; Number: 16K20407 (Grants in Aid for Scientific Research; Japan Society for the Promotion of Science)

Research Project Title: Identifying stem cell-like tumour vascular endothelial cells and their role in the cancer microenvironment

Duration: April 2016 – March 2017

Grant Amount: 2,080,000 Japanese Yen

Role: Principal Investigator